Pharmacovigilance
in one click.

Enter a drug name. Get a complete safety signal profile — adverse events, time-to-onset, and demographic risk — sourced from 1.3 million published case reports, with source citations to back it up.

No account needed. Data from published case reports in the medical literature.

1.3M+Case Reportsfrom 1952–2026
23M+Clinical Eventsacross 125K patients
10K+Adverse Reactionswith causality evidence
<80msQuery Responsemedian response time
Interactive Platform

One click.
Complete signal profile.

Search any compound. Get a structured signal profile with disproportionality scores, demographic breakdown, and onset timing — derived from 1.3M published case reports.

rxQuery
Try these:

Processing Disproportionality

Cross-referencing 1.3M literature reports…

Pembrolizumab

Critical
Major
Moderate
Low
Lit. Cases3,418
Max PRR3.8
Sex Distribution
57%
43%
Age Distribution
020406080+
Ranked Disproportionality Signals
1.
Immune-mediated Colitis
18.2%major
2.
Autoimmune Thyroiditis
12.7%moderate
3.
Hepatotoxicity (Grade 2+)
8.4%major
4.
Pneumonitis
5.1%critical
5.
Adrenal Insufficiency
3.8%moderate
Derived dynamically from literature reports.
Continuous Pipeline

New literature in.
Structured signals out.

PubMed indexes ~148 new case reports per day. Our pipeline ingests, extracts, and structures adverse event data continuously — so your signal profile is never stale.

Ingest

New case reports detected and fetched from PubMed Central as they're published.

Extract

Drug, adverse event, dechallenge, rechallenge, demographics, and outcome — structured from full text with verbatim quotes.

Trigger

PRR and ROR recomputed in real time. New events surface in your signal profile immediately.

Live Ingestion

Article Processing Feed

Active
PMID: 33520245
12:31:01
Warfarin-induced skin necrosis in a patient with protein C deficiency.
Warfarin Skin Necrosis
PMID: 26422825
12:31:01
Methotrexate-induced pneumonitis in rheumatoid arthritis: A clinical challenge.
Methotrexate Pneumonitis
PMID: 31006567
12:31:01
Methotrexate-induced pneumonitis in rheumatoid arthritis: A clinical challenge.
Methotrexate Pneumonitis
Capabilities

A complete pharmacovigilance toolkit.

Adverse Event Profiling

Ranked adverse events per compound.

Frequency, severity, time-to-onset, and PRR — across the full published literature.

StructuredEvent Classification
CitedSource Publications
PRR-WeightedSignal Strength
Pembrolizumab — Top SignalsPRR 3.8
Immune-mediated Colitis
18.2%major
Autoimmune Thyroiditis
12.7%moderate
Hepatotoxicity (Grade 2+)
8.4%major
Pneumonitis
5.1%critical
Adrenal Insufficiency
3.8%moderate

Time-to-Onset Patterns

Median onset timing per adverse event, derived from documented case timelines.

ColitisWk 4–6
ThyroiditisWk 8–12
HepatotoxicityWk 6–10
PneumonitisWk 3–8
Adrenal InsufficiencyWk 12–20

Bar = median onset relative to treatment duration

Risk Stratification

Demographic breakdown per signal.

Sex and age distribution from documented patient profiles in the published literature.

F: 57%Pembro. colitis
55–69Peak age bracket
Regulatory Export

Structured export in E2B(R3) XML or CSV.

Ready for submission workflows and PSUR appendix tables.

E2B(R3) XML pre-fill for submission workflows
PSUR / PBRER appendix tables
Structured CSV export
Real-Time Database Sample

Top compounds by
case volume.

Click any accentuated compound in the list to view its signal profile in the demo above.

Critical (PRR ≥ 5)
Major (PRR 2–5)
Moderate (PRR 1–2)
CyclophosphamideCrit
987
CarbamazepineMaj
843
ValproateMod
689
IbuprofenMod
612
ClozapineMaj
578
InfliximabMod
534

Signal levels reflect peak PRR for each compound.

Regulatory Alignment

Structured around international pharmacovigilance standards.

EMA & FDA Compatible

E2B(R3) ICSR pre-fill for submission workflows.

GVP Module IX

Signal detection and prioritisation aligned with Module IX.

Structured Output

All events categorized and export-ready.

E2B(R3) Pre-fillICSR XML for submission workflows
GVP Module IXSignal management workflow
CSV ExportStructured data for further analysis
REST APIProgrammatic signal access
Flexible Solutions

For safety teams, CROs, and regulatory affairs.

Published case reports indexed1.3M+
Spanning 1952–2026, updated continuously.

Continuous literature surveillance, structured and searchable.

rxQuery aggregates published adverse event evidence, structures it, and surfaces it in one click.

  • Signal detection across 1.3M case reports, updated continuously.
  • PSUR / PBRER appendix tables, pre-formatted.
  • Every signal traced to a cited source publication.
Integration

Web portal or REST API.

Integrates into your existing workflow.

Secure by Design

Encrypted in transit and at rest.

REST API

Authenticated endpoints with audit logging.

Literature-Based

Published case reports with full citations.

See your compound's signal profile.

We'll run a live report for any drug in your portfolio. 20 minutes.